Corcept Therapeutics Incorporated (CORT) ROE US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| ROE, % | ? | 29.9% | 20.2% | 20.9% | 20.6% | 15.4% | 7.51% | ||
| Changes by years, y/y, % | +10pp | -10pp | +1pp | 0pp | -5pp | -5.4% | |||
Corcept Therapeutics Incorporated. ROE, %
Corcept Therapeutics Incorporated. ROE, changes, pp
Corcept Therapeutics Incorporated (CORT) ROE US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| ROE, % | ? | 19.5% | 20.9% | 16.7% | 15.4% | 7.51% | 7.51% | |
| Changes by years, y/y, % | -2pp | 0pp | -5pp | -5pp | -12pp | |||
| Changes by quarters, q/q, % | -1pp | +1pp | -4pp | -1pp | -8pp | |||